| Rights | Preview | Issue Date | Title | Author(s) | Type |
| closedAccess |  | 2017 | A novel neuroprotection target with distinct regulation in stroke and Alzheimer’s disease | Gamir-Morralla, Andrea  ; López-Menéndez, Celia ; Medina, Miguel ; Iglesias, Teresa | capítulo de libro |
| openAccess |  | 9-Apr-2015 | Additional mechanisms conferring genetic susceptibility to Alzheimer’s disease | Calero, Miguel; Gómez Ramos, Alberto; Calero-Rueda, Olga; Soriano, Eduardo; Ávila, Jesús ; Medina, Miguel | artículo |
| openAccess |  | 20-Sep-2018 | Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus | Engel, Tobías; Gómez-Sintes, Raquel ; Alves, Mariana; Jiménez-Mateos, Eva María; Fernández-Nogales, Marta; Sanz-Rodríguez, Amaya; Morgan, James; Beamer, Edward; Rodríguez-Matellán, Alberto G.; Dunleavy, Mark; Takanori, Sano; Ávila, Jesús ; Medina, Miguel ; Hernández Pérez, Félix ; Lucas, José Javier ; Henshall, David C. | artículo |
| closedAccess |  | 2014 | Bioactive prenylated phenyl derivatives derived from marine natural products: Novel scaffolds for the design of BACE inhibitors | López-Ogalla, Javier; García-Palomero, Esther; Sánchez-Quesada, Jorge; Rubio, Laura; Delgado, Elena; García, Pablo; Medina, Miguel ; Castro, Ana ; Muñoz, Pilar | artículo |
| openAccess |  | 2011 | Deconstructing GSK-3: The Fine Regulation of Its Activity | Medina, Miguel ; Wandosell, Francisco | artículo |
| openAccess |  | 16-Aug-2007 | Inhibidores de la acetilcolinesterasa del sitio de unión dual para el tratamiento de la enfermedad de Alzheimer | Martínez, Ana ; Dorronsoro Díaz, Isabel; Rubio Arrieta, Laura; Alonso Gordillo, Diana; Fuertes Huerta, Ana; Morales-Alcelay, Susana; Monte Millan, María del; García-Palomero, Esther; Usan Egea, Paola; Austria, Celia de; Medina, Miguel | patente |
| openAccess |  | 5-Oct-2011 | Modulation of GSK-3 as a therapeutic strategy on tau pathologies | Medina, Miguel ; Garrido Jurado, Juan José ; Wandosell, Francisco | artículo |
| openAccess |  | 5-Oct-2011 | Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies | Medina, Miguel ; Garrido, Juan Jose ; Wandosell, Francisco | artículo |
| openAccess |  | 2011 | Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies. | Medina, Miguel ; Garrido Jurado, Juan José ; Wandosell, Francisco | artículo |
| openAccess |  | 19-Apr-2016 | New features about tau function and dysfunction | Medina, Miguel ; Hernández Pérez, Félix ; Ávila, Jesús | artículo |
| closedAccess |  | 2011 | Overcoming cell death and tau phosphorylation mediated by PI3K-inhibition: a cell assay to measure neuroprotection. | Simón, Diana ; Medina, Miguel ; Ávila, Jesús ; Wandosell, Francisco | artículo |
| openAccess |  | 24-Oct-2014 | The need for better AD animal models | Medina, Miguel ; Ávila, Jesús | artículo |
| openAccess |  | 23-Apr-2014 | The role of extracellular Tau in the spreading of neurofibrillary pathology | Medina, Miguel ; Ávila, Jesús | artículo |
| openAccess |  | 23-Apr-2014 | The role of extracellular Tau in the spreading of neurofibrillary pathology | Medina, Miguel ; Ávila, Jesús | artículo |
| closedAccess |  | 2013 | Understanding the relationship between GSK-3 and Alzheimer's disease: A focus on how GSK-3 can modulate synaptic plasticity processes | Medina, Miguel ; Ávila, Jesús | artículo |
| openAccess |  | 2013 | Use of okadaic acid to identify relevant phosphoepitopes in pathology: A focus on neurodegeneration | Medina, Miguel ; Ávila, Jesús ; Villanueva, Nieves | artículo |
